12:00 AM
 | 
Jun 30, 2008
 |  BioCentury  |  Strategy

Biotherapeutic shopping spree

Biotherapeutic shopping spree

Company/Institution Year Deal type Products/technologies obtained
California Institute for Quantitative Biosciences (QB3) 2008 Research alliance Deal to enable any researcher from UC San Francisco, UC Santa Cruz and/or UC Berkeley to collaborate with Pfizer researchers in any disease area or stage of development; Pfizer will provide up to $9.5M and will have first right to license resulting inventions
Coley 2008 Acquisition Vaccine adjuvants that agonize toll-like receptor 9 (TLR9) to increase the response of both B cells and T cells and TLR7, 8 and 9 agonists and antagonists to treat cancer and inflammatory diseases
CovX 2008 Acquisition

Read the full 644 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >